Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
- Authors:
- Yu‑Xin Liao
- Hai‑Yang Yu
- Ji‑Yang Lv
- Yan‑Rong Cai
- Fei Liu
- Zhi‑Min He
- Shi‑Sheng He
-
Affiliations: Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China, State Key Laboratory of Microbial Metabolism, Sheng Yushou Center of Cell Biology and Immunology, School of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, P.R. China - Published online on: October 18, 2019 https://doi.org/10.3892/ijo.2019.4902
- Pages: 1213-1222
-
Copyright: © Liao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Morrow JJ, Bayles I, Funnell APW, Miller TE, Saiakhova A, Lizardo MM, Bartels CF, Kapteijn MY, Hung S, Mendoza A, et al: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med. 24:176–185. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Isakoff MS, Bielack SS, Meltzer P and Gorlick R: Osteosarcoma: Current treatment and a collaborative pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Sun W, Wang H, Zuo D, Hua Y and Cai Z: Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal. Tumour Biol. 36:1329–1338. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Wang H, Hu Y, Zhang YS, Wen L, Yin F, Wang Z, Zhang Y, Li S, Miao Y, et al: Inhibition of CaMKIIα activity enhances antitumor effect of fullerene C60 nanocrystals by suppression of autophagic degradation. Adv Sci (Weinh). 6:18012332019. View Article : Google Scholar | |
|
Chen R, Wang G, Zheng Y, Hua Y and Cai Z: Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies. J Cell Mol Med. 23:2280–2292. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Duan G and Feng S: MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1. Biochem Biophys Res Commun. 459:367–373. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Luetke A, Meyers PA, Lewis I and Juergens H: Osteosarcoma treatment - where do we stand? A state of the art review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar | |
|
Camuzard O, Santucci-Darmanin S, Carle GF and Pierrefite-Carle V: Role of autophagy in osteosarcoma. J Bone Oncol. 16:1002352019. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar A, Singh UK and Chaudhary A: Targeting autophagy to overcome drug resistance in cancer therapy. Future Med Chem. 7:1535–1542. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
O'Farrill JS and Gordon N: Autophagy in osteosarcoma. Adv Exp Med Biol. 804:147–160. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
D'Arcy MS: Cell death: A review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 43:582–592. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Nagelkerke A, Sweep FC, Geurts-Moespot A, Bussink J and Span PN: Therapeutic targeting of autophagy in cancer. Part I: Molecular pathways controlling autophagy. Semin Cancer Biol. 31:89–98. 2015. View Article : Google Scholar | |
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Nagelkerke A, Bussink J, Geurts-Moespot A, Sweep FC and Span PN: Therapeutic targeting of autophagy in cancer. Part II: Pharmacological modulation of treatment-induced autophagy. Semin Cancer Biol. 31:99–105. 2015. View Article : Google Scholar | |
|
Schott CR, Ludwig L, Mutsaers AJ, Foster RA and Wood GA: The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells. PLoS One. 13:e02064272018. View Article : Google Scholar : PubMed/NCBI | |
|
He H, Ni J and Huang J: Molecular mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett. 7:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hollomon MG, Gordon N, Santiago-O'Farrill JM and Kleinerman ES: Knockdown of autophagy-related protein 5, ATG5, decreases oxidative stress and has an opposing effect on camptothecin-induced cytotoxicity in osteosarcoma cells. BMC Cancer. 13:5002013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Z, Tao L, Shen C, Liu B, Yang Z and Tao H: Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin induced apoptosis. Int J Mol Med. 33:271–276. 2014. View Article : Google Scholar | |
|
Wu W, Li W, Zhou Y and Zhang C: Inhibition of beclin1 affects the chemotherapeutic sensitivity of osteosarcoma. Int J Clin Exp Pathol. 7:7114–7122. 2014.PubMed/NCBI | |
|
Shen C, Wang W, Tao L, Liu B, Yang Z and Tao H: Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1. Int J Mol Med. 32:448–456. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xu ZM, Li CB, Liu QL, Li P and Yang H: Ginsenoside Rg1 prevents doxorubicin-induced cardiotoxicity through the inhibition of autophagy and endoplasmic reticulum stress in mice. Int J Mol Sci. 19:192018. View Article : Google Scholar | |
|
Zhou P, Li Y, Li B, Zhang M, Xu C, Liu F, Bian L, Liu Y, Yao Y and Li D: Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma. Cell Cycle. 17:997–1006. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Guo Y, Huang C, Li G, Chen T, Li J and Huang Z: Paxilitaxel induces apoptosis accompanied by protective autophagy in osteosarcoma cells through hypoxia-inducible factor-1α pathway. Mol Med Rep. 12:3681–3687. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Liu K, Ren T, Huang Y, Sun K, Bao X, Wang S, Zheng B and Guo W: Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma. Cell Death Dis. 8:e30152017. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L and Tang D: HMGB1 promotes drug resistance in osteosarcoma. Cancer Res. 72:230–238. 2012. View Article : Google Scholar | |
|
Huang J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L, Tang D and Ni J: Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy. 8:275–277. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pistoia V and Pezzolo A: Involvement of HMGB1 in resistance to tumor vessel-targeted, monoclonal antibody-based immunotherapy. J Immunol Res. 2016:31423652016. View Article : Google Scholar : PubMed/NCBI | |
|
Kim M, Jung JY, Choi S, Lee H, Morales LD, Koh JT, Kim SH, Choi YD, Choi C, Slaga TJ, et al: GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy. Autophagy. 13:149–168. 2017. View Article : Google Scholar : | |
|
Kim M and Kim DJ: GFRA1: A novel molecular target for the prevention of osteosarcoma chemoresistance. Int J Mol Sci. 19:192018. | |
|
Xu R, Liu S, Chen H and Lao L: MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy. Oncol Rep. 35:1757–1763. 2016. View Article : Google Scholar | |
|
Chen R, Li X, He B and Hu W: MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma. Mol Med Rep. 15:1326–1334. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wei R, Cao G, Deng Z, Su J and Cai L: miR-140-5p attenuates chemotherapeutic drug-induced cell death by regulating autophagy through inositol 1,4,5-trisphosphate kinase 2 (IP3k2) in human osteosarcoma cells. Biosci Rep. 36:362016. View Article : Google Scholar | |
|
Meng Y, Gao R, Ma J, Zhao J, Xu E, Wang C and Zhou X: MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy. Sci Rep. 7:4162017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Jiang K, Jiang H and Wei P: miR-155 mediates drug resistance in osteosarcoma cells via inducing autophagy. Exp Ther Med. 8:527–532. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Tang B, Han H, Mao D, Chen J, Zeng Y and Xiong M: miR-155 affects osteosarcoma MG-63 cell autophagy induced by adriamycin through regulating PTEN-PI3K/AKT/mTOR signaling pathway. Cancer Biother Radiopharm. 33:32–38. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang Y, Wang Y, Zhao W and Wang W: miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy. Tumour Biol. 35:7025–7034. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Wang S, Chen Y, Liu G and Yang X: miR-22 targets the 3′UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy. Tumour Biol. 35:6021–6028. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang P, Zhao ZQ, Guo SB, Yang TY, Chang ZQ, Li DH, Zhao W, Wang YX, Sun C, Wang Y, et al: Roles of microRNA-22 in suppressing proliferation and promoting sensitivity of osteo-sarcoma cells via metadherin-mediated autophagy. Orthop Surg. 11:285–293. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chang Z, Huo L, Li K, Wu Y and Hu Z: Blocked autophagy by miR-101 enhances osteosarcoma cell chemosensitivity in vitro. ScientificWorldJournal. 2014:7947562014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Wu S, Chen Y, Zhao J, Zhang K, Wang J and Chen S: microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma. Exp Biol Med (Maywood). 240:867–875. 2015. View Article : Google Scholar | |
|
Li Y, Jiang W, Hu Y, Da Z, Zeng C, Tu M, Deng Z and Xiao W: MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells. Oncol Lett. 12:4203–4208. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu K, Hou Y, Liu Y and Zheng J: LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci. 24:462017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Liu Z and Wu S: Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy. Oncotarget. 8:31465–31477. 2017.PubMed/NCBI | |
|
Yu Z, Li N, Jiang K, Zhang N and Yao LL: MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR. Eur Rev Med Pharmacol Sci. 22:5867–5873. 2018.PubMed/NCBI | |
|
Wu G, Yu W, Zhang M, Yin R, Wu Y and Liu Q: MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4. Artif Cells Nanomed Biotechnol. 46(Suppl 2): 579–586. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yang C, Gao R, Wang J, Yuan W, Wang C and Zhou X: High-mobility group nucleosome-binding domain 5 increases drug resistance in osteosarcoma through upregulating autophagy. Tumour Biol. 35:6357–6363. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Shimizu T, Sugihara E, Yamaguchi-Iwai S, Tamaki S, Koyama Y, Kamel W, Ueki A, Ishikawa T, Chiyoda T, Osuka S, et al: IGF2 preserves osteosarcoma cell survival by creating an autophagic state of dormancy that protects cells against chemotherapeutic stress. Cancer Res. 74:6531–6541. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhen YF, Li ST, Zhu YR, Wang XD, Zhou XZ and Zhu LQ: Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells. Oncotarget. 7:79417–79427. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Li W, Xu J, Zhang T, Zuo D, Zhou Z, Lin B, Wang G, Wang Z, Sun W, et al: NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy. Cell Death Dis. 8:e30482017. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao X, Wang W, Li Y, Yang D, Li X, Shen C, Liu Y, Ke X, Guo S and Guo Z: HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma. J Exp Clin Cancer Res. 37:2012018. View Article : Google Scholar : PubMed/NCBI | |
|
Tao H, Chen F, Liu H, Hu Y, Wang Y and Li H: Wnt/β-catenin signaling pathway activation reverses gemcitabine resistance by attenuating Beclin1-mediated autophagy in the MG63 human osteosarcoma cell line. Mol Med Rep. 16:1701–1706. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Mukherjee S, Dash S, Lohitesh K and Chowdhury R: The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells. PLoS One. 12:e01792032017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Chen P, Hong H, Wang L, Zhou Y and Lang Y: JNK pathway mediates curcumin-induced apoptosis and autophagy in osteosarcoma MG63 cells. Exp Ther Med. 14:593–599. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Guan J, Yuan Z, He J, Wu Z, Liu B, Lin X, Mo L and Mo H: Overexpression of caveolin-1 reduces Taxol resistance in human osteosarcoma cells by attenuating PI3K-Akt-JNK dependent autophagy. Exp Ther Med. 12:2815–2822. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B and Bao JK: Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 45:487–498. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Yang Z, Li Y, Xia J, Li D, Li H, Ren M, Liao Y, Yu S, Chen Y, et al: Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment. Oncotarget. 7:44763–44778. 2016.PubMed/NCBI | |
|
Zhao S, Lu N, Chai Y and Yu X: Rapamycin inhibits tumor growth of human osteosarcomas. J BUON. 20:588–594. 2015.PubMed/NCBI | |
|
Zhao GS, Gao ZR, Zhang Q, Tang XF, Lv YF, Zhang ZS, Zhang Y, Tan QL, Peng DB, Jiang DM, et al: TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis. J Exp Clin Cancer Res. 37:1882018. View Article : Google Scholar : PubMed/NCBI | |
|
Huang JC, Cui ZF, Chen SM, Yang LJ, Lian HK, Liu B, Su ZH, Liu JS, Wang M, Hu ZB, et al: NVP-BEZ235 synergizes cisplatin sensitivity in osteosarcoma. Oncotarget. 9:10483–10496. 2017. | |
|
Meschini S, Condello M, Marra M, Formisano G, Federici E and Arancia G: Autophagy-mediated chemosensitizing effect of the plant alkaloid voacamine on multidrug resistant cells. Toxicol In Vitro. 21:197–203. 2007. View Article : Google Scholar | |
|
Huang K, Chen Y, Zhang R, Wu Y, Ma Y, Fang X and Shen S: Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. 9:1572018. View Article : Google Scholar : PubMed/NCBI | |
|
Yen JH, Huang ST, Huang HS, Fong YC, Wu YY, Chiang JH and Su YC: HGK-sestrin 2 signaling-mediated autophagy contributes to antitumor efficacy of Tanshinone IIA in human osteosarcoma cells. Cell Death Dis. 9:10032018. View Article : Google Scholar : PubMed/NCBI | |
|
Kang Y, He P, Wang H, Ye Y, Li X, Xie P and Wu B: Brazilin induces FOXO3A-dependent autophagic cell death by disturbing calcium homeostasis in osteosarcoma cells. Cancer Chemother Pharmacol. 82:479–491. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Zhang Y, Zou J, Yan L, Yu X, Lu P, Wu X, Li Q, Gu R and Zhu D: Andrographolide induces autophagic cell death and inhibits invasion and metastasis of human osteosarcoma cells in an autophagy-dependent manner. Cell Physiol Biochem. 44:1396–1410. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Ma R, Cheng S and Gu G: Marrubenol inhibits osteosarcoma cancer cell growth by inducing autophagic cell death and inhibiting cancer cell migration and invasion. J BUON. 23:729–734. 2018.PubMed/NCBI | |
|
Liu ZR, Sun LZ, Jia TH and Jia DF: β-Aescin shows potent antiproliferative activity in osteosarcoma cells by inducing autophagy, ROS generation and mitochondrial membrane potential loss. J BUON. 22:1582–1586. 2017. | |
|
Zhu J, Yu W, Liu B, Wang Y, Shao J, Wang J, Xia K, Liang C, Fang W, Zhou C, et al: Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo. Cell Death Dis. 8:e31132017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang D, Zhang H, Wu J, Ma R, Li Z, Wang K and Yang F: The role of chamaejasmine in cellular apoptosis and autophagy in MG-63 cells. Biosci Rep. 39:392019. View Article : Google Scholar | |
|
Zhang C and Wang LM: Inhibition of autophagy attenuated curcumol-induced apoptosis in MG-63 human osteosarcoma cells via Janus kinase signaling pathway. Oncol Lett. 14:6387–6394. 2017.PubMed/NCBI | |
|
Liao YX, Zhou CH, Zeng H, Zuo DQ, Wang ZY, Yin F, Hua YQ and Cai ZD: The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review). Int J Mol Med. 32:1239–1246. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bao X, Zhao L, Guan H and Li F: Inhibition of LCMR1 and ATG12 by demethylation-activated miR-570-3p is involved in the anti-metastasis effects of metformin on human osteosarcoma. Cell Death Dis. 9:6112018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Yan T, Guo W, Sun K, Wang S, Bao X, Liu K, Zheng B, Zhang H and Ren T: Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy. J Exp Clin Cancer Res. 37:1352018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Bao F, Teng Y, Li Q and Li J: MicroRNA-506-3p initiates mesenchymal-to-epithelial transition and suppresses autophagy in osteosarcoma cells by directly targeting SPHK1. Biosci Biotechnol Biochem. 83:836–844. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liao YX, Fu ZZ, Zhou CH, Shan LC, Wang ZY, Yin F, Zheng LP, Hua YQ and Cai ZD: AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments. Oncol Rep. 34:33–42. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yu F, Li J, Xie Y, Sleightholm RL and Oupicky D: Polymeric chloroquine as an inhibitor of cancer cell migration and experimental lung metastasis. J Control Release. 244:347–356. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yu W, Wang Y, Zhu J, Jin L, Liu B, Xia K, Wang J, Gao J, Liang C and Tao H: Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy. Biomaterials. 192:128–139. 2019. View Article : Google Scholar | |
|
Ren T, Zheng B, Huang Y, Wang S, Bao X, Liu K and Guo W: Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways. Cell Death Dis. 10:2612019. View Article : Google Scholar : PubMed/NCBI | |
|
Livingston JA, Wang WL, Tsai JW, Lazar AJ, Leung CH, Lin H, Advani S, Daw N, Santiago-O'Farrill J, Hollomon M, et al: Analysis of HSP27 and the autophagy marker LC3B+ puncta following preoperative chemotherapy identifies high-risk osteo-sarcoma patients. Mol Cancer Ther. 17:1315–1323. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Wang Q, Zhou Y, Sun L, Hu B, Xue H, Li M, Zhang K, Ren C, Duan N, et al: Overexpression of p62 is associated with poor prognosis and aggressive phenotypes in osteosarcoma. Oncol Lett. 15:9889–9895. 2018.PubMed/NCBI | |
|
Ma H, Li X, Wang J, Hornicek FJ, Garbutt CC, Chang X and Duan Z: Expression and clinical implication of autophagy-associated protein p62 in osteosarcoma. Oncology. 95:52–60. 2018. View Article : Google Scholar : PubMed/NCBI |
